UBS has recently initiated Clover Health Investments Corp (CLOV) stock to Neutral rating, as announced on October 7, 2024, according to Finviz. Earlier, on February 2, 2022, Cowen had raised the stock ...
Clover Leaf Capital Corp. (NASDAQ: CLOEU) has closed its previously announced initial public offering of some 13,831,230 units at $10 per unit</ Jelena Martinovic Watch Planet 13's CEO & Matt ...
David Tsay, M.D., was appointed chief medical officer of Counterpart Health, a Clover Health subsidiary, this month. | Clover ...
Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Clover Health Investments (CLOV – Research Report) and keeping ...
Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software ...
“We are proud to reaffirm our commitment to New Jersey by maintaining our affordable benefit-rich PPO plans for 2025,” said Jamie Reynoso, Clover’s CEO of Medicare Advantage. “At a time when many ...
Clover Health is an insurance company that offers a variety of Medicare Advantage plans. Read on to learn where Clover Health where plans are available in the U.S., as well as details about the ...
On Friday, Clover Health Investments Corp (CLOV) stock saw a modest uptick, ending the day at $4.07 which represents a slight increase of $0.12 or 3.04% from the prior close of $3.95. The stock opened ...
Short interest in Clover Leaf Capital Corp (OTC:CLOE) decreased during the last reporting period, falling from 3.22K to 2.73K. This put 0.29% of the company's publicly available shares short.
In response to the impending delisting, Clover Leaf's units, Class A common stock, and rights are expected to trade on the OTC Markets under the tickers "CLOEU," "CLOE," and "CLOER," respectively.
Oct. 15, 2024 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV ... low specialist and prescription drug copays, enhanced OTC and dental allowances, and a rewards program with the potential ...